| Financial Year |
March 31 2023 |
| Monetary Funds |
803,605,541.18 |
| Held-for-trading Financial Assets |
82,578,341.84 |
| Notes Receivable |
-- |
| Accounts Receivable |
515,868,301.15 |
| Advances to Suppliers |
39,950,583.97 |
| Other Receivables |
71,690,096.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,195,331,278.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
75,836,919.16 |
| Total Current Assets |
3,784,861,062.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
51,475,753.41 |
| Investment Properties |
-- |
| Fixed Assetes |
898,919,928.33 |
| Under-construction Projects |
184,510,132.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
88,882,263.68 |
| R&D expenses |
-- |
| Goodwill |
2,255,004,432.63 |
| Long-Term Deferred and Prepaid Expenses |
399,592,266.80 |
| Deferred Income Tax Assets |
281,770,443.98 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
5,675,773,748.70 |
| Total Assets |
9,460,634,810.71 |
| Short-Term Loans |
155,086,611.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
971,860,526.45 |
| Accounts Payable |
1,872,997,318.66 |
| Accounts Received In Advance |
3,952,327.49 |
| Employee Compensation Payable |
125,550,522.97 |
| Taxes Payable |
72,964,890.07 |
| Interest Payable |
-- |
| Dividend Payable |
509,261.19 |
| Other payables |
263,956,092.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
579,879,638.85 |
| Other Current Liabilities |
107,012.11 |
| Sub-Total of Current Liabilities |
4,083,616,934.73 |
| Long-term Loans |
1,115,783,161.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
411,537,574.88 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
271,211,459.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,732,813,592.16 |
| Total Liabilities |
6,816,430,526.89 |
| Paid-In Capital(Or Share Stock) |
99,162,533.00 |
| Capital Surplus |
1,392,064,822.01 |
| Surplus Reserve |
88,032,474.46 |
| LESS:Treasury Stock |
14,783,878.20 |
| Undistributed Profits |
1,097,146,122.32 |
| Minority Stockholder's Interest |
-17,417,789.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,661,622,073.59 |
| Owner's Equity（Stockholder's Equity） |
2,644,204,283.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,460,634,810.71 |
